Integral Diagnostics
Integral Diagnostics is a leading provider of medical imaging services in Australia and New Zealand, offering a comprehensive range of diagnostic imaging services. The company is known for its advanced technology and skilled radiologists, ensuring high-quality patient care and accurate diagnostics.
Short position
Integral Diagnostics (ASX:IDX) has 1.78% of its shares on issue reported as short positions as of 5 Oct 2026, or about 6,666,607 shares. Over the past 30 days that figure has fallen 0.38 percentage points, and over 90 days it has risen 0.40 percentage points. Its highest recorded short interest was 5.56% in October 2024. IDX is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Integral Diagnostics (IDX) short interest history
IDX Short Interest History
- 30-day change
- -0.38pp
- 90-day change
- +0.40pp
- 1-year change
- -1.82pp
- All-time high
- 5.56% (October 2024)
- All-time low
- 0.00% (November 2016)
Is IDX heavily shorted?
Not especially: 1.78% short interest is modest by ASX standards, ranking #174 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has IDX's short interest changed recently?
Over the past 30 days Integral Diagnostics's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 1.78% of shares on issue.
What is the highest IDX's short interest has been?
Since 2015, Integral Diagnostics's short interest peaked at 5.56% in October 2024 and bottomed at 0.00% in November 2016.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2015. See our methodology.